54 /100
HIGH RISK
Score updated Jun 16, 2026

VBIO — Valion Bio, Inc. Dilution Risk Tracker

Track VBIO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track VBIO — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
65
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
58%
🔄 Reverse Split 65%
• 50-day avg $0.99 below $1 exchange minimum
• 9 months cash with weak price
🔁 Convertible Conversion 60%
• Major convertible overhang: 102% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration 40%
• Score rose 18 points recently (worsening)
🔔 Track VBIO — Get forecast alerts →

💹 Market Data

Market Cap$2.45M
Shares Outstanding3.20M
Float2.76M
Cash$7.21M
Debt$6.45M
Short InterestN/A

🏛 Institutional Holdings

10.5% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track VBIO for full holder detail →

📉 Short Interest

Short Interest203.3K
Days to Cover1.0
% of Float7.4%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track VBIO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking VBIO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

🔬 More Research for VBIO
📊 VBIO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 VBIO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.